These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
326 related items for PubMed ID: 18331395
1. Protective effect of a multiantigenic DNA vaccine against Toxoplasma gondii with co-delivery of IL-12 in mice. Cui YL, He SY, Xue MF, Zhang J, Wang HX, Yao Y. Parasite Immunol; 2008 May; 30(5):309-13. PubMed ID: 18331395 [Abstract] [Full Text] [Related]
3. Induction of protective immunity by multiantigenic DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice. Qu D, Yu H, Wang S, Cai W, Du A. Vet Parasitol; 2009 Dec 23; 166(3-4):220-7. PubMed ID: 19740610 [Abstract] [Full Text] [Related]
6. Comparison of cholera toxin A2/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine. Xue M, He S, Zhang J, Cui Y, Yao Y, Wang H. Exp Parasitol; 2008 Jul 23; 119(3):352-7. PubMed ID: 18442818 [Abstract] [Full Text] [Related]
7. Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice. Meng M, He S, Zhao G, Bai Y, Zhou H, Cong H, Lu G, Zhao Q, Zhu XQ. Parasit Vectors; 2012 Nov 26; 5():273. PubMed ID: 23181694 [Abstract] [Full Text] [Related]
8. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice. Mévélec MN, Bout D, Desolme B, Marchand H, Magné R, Bruneel O, Buzoni-Gatel D. Vaccine; 2005 Aug 22; 23(36):4489-99. PubMed ID: 15935521 [Abstract] [Full Text] [Related]
13. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii. Cong H, Gu QM, Jiang Y, He SY, Zhou HY, Yang TT, Li Y, Zhao QL. Parasite Immunol; 2005 Aug 22; 27(1-2):29-35. PubMed ID: 15813720 [Abstract] [Full Text] [Related]
17. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model. Fang R, Feng H, Nie H, Wang L, Tu P, Song Q, Zhou Y, Zhao J. Vaccine; 2010 Feb 17; 28(7):1803-7. PubMed ID: 20018269 [Abstract] [Full Text] [Related]
18. [Construction of monovalent and compound nucleic acid vaccines against Toxoplasma gondii with gene encoding p30]. Yang TT, He SY, Jiang H, Gu QM, Cong H, Zhou HY, Zhang JQ, Li Y, Zhao QL. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Feb 28; 23(1):14-7. PubMed ID: 16042200 [Abstract] [Full Text] [Related]
19. Protection in mice immunized with a heterologous prime-boost regime using DNA and recombinant pseudorabies expressing TgSAG1 against Toxoplasma gondii challenge. Shang L, Liu Q, Liu W, Men J, Gao S, Jiang L, Wang Z, Zhai Y, Jin H, Lian H, Chen C, Xia Z, Yuan Z, Zhu XQ. Vaccine; 2009 May 11; 27(21):2741-5. PubMed ID: 19428887 [Abstract] [Full Text] [Related]
20. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis. Dziadek B, Gatkowska J, Brzostek A, Dziadek J, Dzitko K, Grzybowski M, Dlugonska H. Vaccine; 2011 Jan 17; 29(4):821-30. PubMed ID: 21087690 [Abstract] [Full Text] [Related] Page: [Next] [New Search]